Related Experiment Video
Updated: Jul 5, 2025
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
17.9K
The renin angiotensin aldosterone system
Hannah Triebel1, Hayo Castrop2
1Institute of Physiology, University of Regensburg, Universitätsstr. 31, 93040, Regensburg, Germany.
Pflugers Archiv : European Journal of Physiology
|January 17, 2024
Summary
This review details the renin-angiotensin-aldosterone system (RAAS), its regulatory feedback mechanisms, and its significant impact on blood pressure via volume homeostasis and vascular tone.
Area of Science:
- Physiology
- Cardiovascular Science
- Endocrinology
Background:
- The renin-angiotensin-aldosterone system (RAAS) is a critical hormonal cascade involved in cardiovascular regulation.
- Understanding the RAAS is essential for comprehending blood pressure control and fluid balance.
Purpose of the Study:
- To provide a comprehensive overview of the RAAS.
- To elucidate the regulatory mechanisms governing the RAAS.
- To detail the RAAS's effects on volume homeostasis and vascular tone.
Main Methods:
- This study is a review of existing literature.
- It synthesizes information on the proteolytic cascade of the RAAS.
- It examines feedback control parameters and major physiological effects.
Main Results:
- The RAAS involves a complex proteolytic cascade.
- Multiple feedback-controlled parameters regulate RAAS activity.
- The RAAS significantly influences volume homeostasis and vascular tone.
Conclusions:
- The RAAS plays a pivotal role in maintaining arterial blood pressure.
- Its regulation is intricate, involving numerous feedback loops.
- Understanding these aspects is crucial for cardiovascular health research.
Related Concept Videos
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
631
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
631
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
734
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
734
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:17Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K